Clinical trial
The Addition of Montelukast to Fluticasone in the Treatment of Perennial…
NCT00119015 · University of Chicago, Other · Terminated
Key facts
| NCT number | NCT00119015 |
|---|---|
| Title | The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis |
| Official title | The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis |
| Lead sponsor | University of Chicago, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | Placebo, Montelukast, Fluticasone propionate |
| Enrollment | 102 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jul 12, 2005 |
| Last update posted | Feb 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: